Ian Gust

Q: What Schools Are Affiliated With Ian Gust

Ian Gust is affiliated with the following schools: University of Melbourne, Pompeu Fabra University, University of Cambridge

Ian Gust's AcademicInfluence.com Rankings

Ian Gust

Biology

#3296

World Rank

#5054

Historical Rank

Virology

#136

World Rank

#140

Historical Rank

biology Degrees

Download Badge

Biology

Ian Gust's Degrees

Bachelors Microbiology University of Melbourne

Why Is Ian Gust Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ian David Gust AO, FRCPA, FRACP, MASM, FT is an Australian medical researcher, virologist, and former science administrator. Gust's area of work is in the development of drugs and vaccines against viral diseases and he is best known for the development of vaccines against the Hepatitis A virus. He currently serves as a non–executive company director and consultant.

(See a Problem?)

Ian Gust's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Global Circulation of Seasonal Influenza A (H3N2) Viruses (2008) (692)
Acquired immune deficiency syndrome (1983) (256)
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. (2008) (221)
Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. (1996) (210)
Epidemiological patterns of hepatitis A in different parts of the world. (1992) (169)
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage (1981) (144)
Therapeutic Immunisation against hellcobacter Infection (1994) (115)
Enterovirus type 71 infection in Melbourne. (1974) (112)
Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS. (1990) (96)
Taxonomic classification of hepatitis A virus. (1983) (93)
IMMUNOGLOBULIN M ANTIBODIES AGAINST HEPATITIS B CORE ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION (1984) (90)
Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. (1995) (88)
A global pandemic influenza vaccine action plan. (2006) (88)
Taxonomic classification of human hepatitis B virus. (1986) (83)
Sequence conservation and divergence of hepatitis δ virus RNA (1990) (81)
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. (1990) (77)
The increased risk of fatal liver disease in renal transplant patients who are hepatitis Be antigen and/or HBV DNA positive. (1991) (75)
The antibody response following hepatitis A infection. (1977) (73)
Detection of hepatitis A virus in the feces of patients with naturally acquired infections. (1980) (70)
Deadly Choices : How the Anti-Vaccine Movement Threatens Us All (2012) (69)
Mode of action of adjuvants: implications for vaccine safety and design. (2010) (66)
Biophysical and biochemical characterization of hepatitis A virus. (1982) (63)
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compounds (1990) (59)
Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A-specific immunoglobulin M (1979) (58)
IS LACTASE THE RECEPTOR AND UNCOATING ENZYME FOR INFANTILE ENTERITIS (ROTA) VIRUSES? (1976) (58)
VIRAEMIA IN INFLUENZA: A REPORT OF TWO CASES (1971) (58)
The origin of the HM175 strain of hepatitis A virus. (1985) (56)
Virus and virus‐like particles in the faeces of cats with and without diarrhoea (1987) (54)
Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. (1982) (53)
MUSSEL-ASSOCIATED VIRAL HEPATITIS, TYPE A: SEROLOGICAL CONFIRMATION (1976) (50)
Monoclonal antibodies against hepatitis A virus (1983) (49)
Report of a workshop: waterborne non-A, non-B hepatitis. (1987) (48)
A study of the prevalence of rotavirus infection in children with gastroenteritis admitted to an infectious diseases hospital (1977) (47)
Tectonic evolution of the northern New England Fold Belt: the Permian-Triassic Hunter-Bowen event (2015) (47)
Relationship between prevalence of antibody to hepatitis A antigen and age: a cohort effect? (1978) (45)
The Cholera Crisis in Africa (2009) (45)
The relationship between a 27-nm virus-like particle and hepatitis A as demonstrated by immune electron microscopy. (1974) (45)
Viruses and virus‐like particles in the faeces of dogs with and without diarrhoea (1984) (45)
A seroepidemiologic study of infection with HAV and HBV in five Pacific Islands. (1979) (45)
Restricted replication of human hepatitis A virus in cell culture: intracellular biochemical studies (1981) (44)
Hepatitis delta virus infection in the world: Epidemiological patterns and clinical expression (1992) (44)
SHORT COMMUNICATION: Testing of saliva for antibodies to HIV‐1 (1991) (44)
A Global Lab Against Influenza (2001) (43)
Evaluation of enzyme-linked immunosorbent assays: a method of data analysis. (1988) (43)
Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A virus (1978) (42)
Human rotavirus and its antibody: their coexistence in feces of infants (1978) (42)
Sequence conservation and divergence of hepatitis delta virus RNA. (1990) (41)
Development of vaccines against influenza H5. (2006) (40)
The polypeptides of hepatitis A virus. (1978) (39)
Isolation of feline rotaviruses and their relationship to human and simian isolates by electropherotype and serotype. (1985) (39)
Immunisation against hepatitis B. (1980) (39)
Toward a Human Vaccines Project (2014) (39)
Development and evaluation of influenza pandemic vaccines (2006) (38)
Planning for the next pandemic of influenza (2001) (38)
Antigenic analysis of rotavirus isolates using monoclonal antibodies specific for human serotypes 1, 2, 3 and 4, and SA11. (1986) (38)
Update: influenza activity--United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine. (2000) (37)
Coproantibodies in hepatitis A: detection by enzyme-linked immunosorbent assay and immune electron microscopy (1980) (37)
Replication of human rotavirus in cell culture (1983) (36)
Complement-fixing antibody response to rotavirus infection (1977) (35)
An evaluation of competitive and second generation ELISA screening tests for antibody to HIV. (1988) (34)
Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo (1990) (34)
Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference. (2010) (32)
Autoantibody to intermediate filaments in viral hepatitis. (1981) (32)
ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis. (1983) (32)
Evidence that the genome of hepatitis A virus consists of single-stranded RNA (1981) (30)
INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDS (1989) (30)
Comparison of electron microscopy, enzyme-linked immunosorbent assay, solid-phase radioimmunoassay, and indirect immunofluorescence for detection of human rotavirus antigen in faeces. (1979) (29)
Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. (1986) (29)
Faecal antigen in viral hepatitis. (1970) (29)
Detection of markers of hepatitis B infection in serum dried on to filter-paper: an application to field studies. (1982) (29)
THE PREVALENCE OF ANTIBODY TO HEPATITIS A VIRUS IN TWO POPULATIONS IN VICTORIA (1977) (29)
Live attenuated vaccine for hepatitis A. (1983) (28)
Isolation of HIV from Australian patients with AIDS, AIDS related conditions and healthy antibody positive individuals. (1987) (28)
A prospective study of acute viral hepatitis with particular reference to hepatitis A. (1976) (28)
Murray Valley encephalitis in Australia, 1974: antibody response in cases and community. (1976) (28)
Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model (1990) (28)
Delta agent infection in melbourne (1984) (27)
An epidemic associated with echovirus type 18 (1972) (27)
Physicochemical stability and inactivation of human and simian rotaviruses (1987) (26)
Subgrouping of respiratory syncytial virus strains from Australia and Papua New Guinea by biological and antigenic characteristics (2005) (26)
Nucleotide sequence of high-passage hepatitis A virus strain HM175: comparison with wild-type and cell culture-adapted strains. (1989) (25)
Virus-like particles in Australia-antigen-associated hepatitis. (1970) (24)
Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. (1986) (24)
Patterns of migration indicate sexual transmission of HTLV‐I infection in non‐pregnant women in papua new guinea (1989) (23)
Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies. (1990) (23)
Studies on hepatitis B surface antigen and antibody in Nauru. I. Distribution amongst Nauruans. (1978) (23)
Iodination of hepatitis A virus reveals a fourth structural polypeptide (1980) (22)
Detection of IgM Antibodies to Delta Antigen After Coinfection and Superinfection With the Delta Virus (1986) (22)
Recognition of envelope and tat protein synthetic peptide analogs by HIV positive sera or plasma (1988) (21)
Virus-like particles associated with a faecal antigen from hepatitis patients and with Australia antigen. (1971) (21)
Coronavirus-like particles and other agents in the faeces of children in Efate, Vanuatu. (1982) (20)
Prolonged outbreak of Norwalk gastroenteritis in an isolated guest house (1985) (20)
Detection of hepatitis A virus and antibody by solid-phase radioimmunoassay and enzyme-linked immunosorbent assay with monoclonal antibodies (1985) (20)
Control of HBV and HDV infection in an isolated pacific Island: 1. pattern of infection (1989) (19)
Hepatitis B virus infections in Melanesians and Polynesians in New Caledonia. (1981) (19)
Studies on hepatitis B surface antigen and antibody in Nauru. II. Distribution amongst Gilbert and Ellice (Tuvalu) islanders. (1978) (19)
A preliminary evaluation of five HIV antigen detection assays. (1988) (19)
Control of hepatitis B in Australia: The case for alternative strategies (1992) (19)
Detection of anti-HIV immunoglobulin M by particle agglutination following acute HIV infection. (1989) (19)
Some aspects of the mode of action of imipramine. (1963) (18)
Serum immunoglobulin levels in acute A, B, and non-A, non-B hepatitis. (1982) (18)
Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007. (2008) (18)
Seroepidemiology of infection with hepatitis A and B viruses in an isolated Pacific population. (1979) (17)
Hepatitis A virus and hepatitis A infection. (1991) (17)
Prevalence of infection with hepatitis C virus in Australia (1989) (16)
Investigation of Topoisomerase Inhibitors for Activity against Human Immunodeficiency Virus: Inhibition by Coumermycin A1 (1990) (16)
Design of hepatitis A vaccines. (1990) (16)
Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria: Relationship with other blood borne viruses and liver disease (1992) (16)
AN EXTENSIVE ROTAVIRUS OUTBREAK IN ABORIGINAL INFANTS IN CENTRAL AUSTRALIA (1977) (16)
Seroepidemiology of infection with hepatitis B virus in Fiji. (1982) (16)
Immunisation against hepatitis B in Taiwan. (1996) (15)
Functional studies of hepatitis delta antigen and delta virus RNA. (1991) (15)
A longitudinal study of hepatitis infection in an institution for the mentally retarded. (1982) (14)
Hepatitis in the tropics (1993) (14)
Use of heat‐treated clotting‐factor concentrates in patients with haemophilia and a high exposure to HTLV‐III (1985) (14)
Further characterization of 41 isolates of adenovirus types 19/37 by serum neutralization and DNA restriction enzyme analysis (1986) (13)
AIDS vaccine development: challenges and opportunities. (2007) (13)
Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety. (2013) (13)
Absence of Au antigen in faeces of patients with Au-positive sera. (1971) (12)
On the aetiology of whooping cough (1973) (12)
Non-B hepatitis in Melbourne: a serological study of hepatitis A virus infection. (1977) (12)
HTLV‐I infection in selected populations in Australia and the western Pacific region (1992) (12)
Radioimmunofocus assay for detection and quantitation of human rotavirus (1984) (12)
Sewage pollution of marine waters: the risks of viral infection (1989) (12)
Factors affecting the prevalence of infection with hepatitis B virus among non-pregnant women in the Alexishafen area of Papua New Guinea. (1989) (11)
Arbovirus infection in a Murray Valley community. (1986) (11)
Molecular cloning of cDNA from hepatitis A virus strain HM-175 after multiple passages in vivo and in vitro. (1986) (11)
Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986. (1987) (11)
Hepatitis B Infection in Vanuatu: Age of Acquisition of Infection and Possible Routes of Transmission (1989) (11)
Hepatitis C antibody testing: problems associated with non-specific binding. (1991) (11)
Comparison of enzyme immunoassay and reverse transcriptase assay for detection of HIV in culture supernates. (1987) (11)
Epidemiology of hepatitis D virus (delta) infection in Melbourne over a 15‐year period (1986) (10)
Prevalence of antibody to hepatitis A and polioviruses in an unimmunized urban population. (1978) (10)
The covert liver disease of drug addicts. (1974) (10)
Purification of hepatitis A virus from human feces. (1978) (10)
A cross sectional study of markers of hepatitis B infection in Niue. (1983) (10)
The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded. (1978) (10)
AUSTRALIA ANTIGEN IN ACUTE HEPATITIS IN MELBOURNE (1971) (9)
Detection of delta infection using reagents obtained from the serum of patients infected with HBV. (1984) (9)
ADENOVIRUS TYPE 4 IN MELBOURNE, 1969‐1971 (1974) (9)
The pros and cons of immunisation. (1995) (9)
PARTICLE AGGLUTINATION ASSAY FOR ANTI-HIV (1987) (9)
Comparison of core antigen (p24) assay and reverse transcriptase activity for detection of human immunodeficiency virus type 1 replication (1989) (9)
Two antigenic specificities in the Australia antigen. (1971) (9)
A vaccine against hepatitis A--at last. (1992) (9)
The prevalence of hepatitis B infection amongst urban and rural populations in Western Samoa (1981) (9)
HEPATITIS A (1977) (9)
A solid-phase enzyme-linked immunosorbent assay (ELISA) for detection of antibody to rubella virus. (1979) (8)
HDV infection in the Western Pacific region. (1991) (8)
An epidemic of influenza in the population of niue (1985) (8)
Indirect immunofluorescence assay for the detection of hepatitis A virus-specific serum immunoglobulins (1986) (8)
Serological markers of hepatitis B infection in Niue children. (1985) (8)
Recent developments in hepatitis A. (1978) (8)
Clinical, serologic, and epidemiologic aspects of hepatitis A virus infection. (1986) (8)
AN EVALUATION OF THE TECHNIQUES USED FOR THE DETECTION OF AUSTRALIA ANTIGEN AND ANTIBODY (1971) (8)
Hepatitis B control: lessons from the International Task Force on Hepatitis B Immunization and the Lombok Hepatitis B Model Immunization Project. (1993) (8)
Pregnancy Complicated by Accidental Rubella Vaccination (1973) (8)
A seroepidemiological study of hepatitis B amongst Fiji health care workers. (1991) (8)
A RETROSPECTIVE STUDY OF THE INCIDENCE OF HEPATITIS B IN MELBOURNE DURING 1954 (1974) (7)
Comparison of passive haemagglutination and haemagglutination-inhibition techniques for detection of antibodies to rubella virus. (1979) (7)
A study of the distribution of the major subtypes of hepatitis B antigen in Melbourne. (1974) (6)
Australia antigen and Down's syndrome. (1972) (6)
Coronavirus‐like particles in adults in melbourne, Australia (1989) (6)
Hepatitis in male homosexuals in Melbourne (1983) (6)
Evaluation of a new assay for antibodies to LAV/HTLV III. (1986) (6)
Hepatitis B immunoglobulin (1982) (5)
Pathology and pathophysiology of AIDS and HIV‐related diseases. (1990) (5)
PITFALLS IN HEPATITIS A (1974) (5)
HAND, FOOT AND MOUTH DISEASE: AN OUTBREAK WITH INTERESTING VIROLOGICAL FEATURES (1973) (4)
Detection of antibodies to single‐stranded dna in naturally acquired and experimentally induced viral hepatitis (1980) (4)
L'hépatite virale (1983) (4)
A survey of rubella haemagglutination-inhibition testing in the southern states of Australia. (1973) (4)
Towards the control of hepatitis B: An historical review (1986) (4)
Hepadnaviridae: Hepatitis B Virus and the Delta Virus (1988) (4)
Hepatitis B in Victoria. (1982) (4)
Immunization against hepatitis B (1983) (4)
Epidémiologie de l'hépatite A (1992) (4)
Control of hepatitis B in the Western Pacific region (1986) (4)
Delta infection in Pacific Islanders (1984) (4)
Epidemiology of HDV infection in Australia and the Western Pacific Region. (1987) (4)
Enterically Transmitted Non-A, Non-B Hepatitis (2018) (4)
Acute viral hepatitis. (1978) (4)
Restrictive events in the replication of hepatitis A virus in vitro. (1985) (3)
Cellular changes associated with persistent hepatitis A infectionin vitro (2005) (3)
PREVALENCE OF ANTIBODY TO HEPATITIS B VIRUS IN MELBOURNE (1978) (3)
How an outbreak of hepatitis A in Melbourne led to the development of a vaccine. (1992) (3)
Viral hepatitis. (1982) (3)
The effect of glucocorticoid hormones on release of HBsAg from PLC/PRF/5 (Alexander) hepatoma cells. (1983) (3)
Viral Hepatitis and Its Control (1978) (3)
Virus-like particles in Australia-antigenassociated hepatitis. (1970) (3)
Immunologic mechanisms in hepatitis B assayed by antigen-binding lymphocytes. (1975) (3)
ACUTE NON-BACTERIAL GASTROENTERITIS: COLLECTION OF LARGE QUANTITIES OF STOOLS FROM YOUNG CHILDREN (1975) (2)
Diagnostic tests for the human immunodeficiency virus (1989) (2)
Not so sweet homes--hepatitis A in institutions. (1994) (2)
DURATION OF ANTIGENAEMIA IN AU‐POSITIVE VIRAL HEPATITIS1 (1971) (2)
Hepatitis A. (1987) (2)
MAINTENANCE DIALYSIS OF PATIENTS INFECTED WITH HEPATITIS B VIRUS (1981) (2)
Virus and virus-like particles in the feces of normal laboratory mice. (1991) (2)
Detection of hepatitis b surface antigen in patients with acute viral hepatitis. (1976) (2)
Standardisation and licensing of combination vaccines based on DTP. (1999) (2)
A prospective study ofacute viral hepatitis withparticular reference tohepatitis A (1976) (2)
Towards a hepatitis A vaccine. A review (1984) (2)
Issues about pertussis vaccines (1998) (2)
Human rotavirus infection in Efate, Vanuatu. (1982) (2)
AN EVALUATION OF THE USE OF SENSITIZED LATEX PARTICLES FOR THE DETECTION OF THE HEPATITIS‐ASSOCIATED ANTIGEN (1973) (2)
Hepatitis A Infection: Clinical Aspects (1989) (1)
Diethanolamine fusidate has no in-vitro activity against the human immunodeficiency virus. (1988) (1)
Hepatitis B in urban Australian school children (1994) (1)
Letter: Pitfalls in hepatitis A? (1974) (1)
Diethanolamine fusidate has no in‐vitro activity against the human immunodeficiency virus (1988) (1)
The 1984 International Symposium on Viral Hepatitis (1984) (1)
Of viruses, horses and men (1995) (1)
Aetiology of acute hepatitis in Malaysia. (1986) (1)
Letter: Influenza epidemic? (1976) (1)
HTLV‐I infection in selected populations in Australia and the western Pacific region (1992) (1)
Penicillin: World War II infections and Howard Florey (2014) (1)
STUDIES WITH A LIVE INFLUENZA A VACCINE IN ARMY PERSONNEL (1977) (1)
Patents and literature (1986) (1)
Hepatitis B infection in Funafuti. (1978) (1)
Global Perspective of Viral Hepatitis and Liver Disease: The Western Pacific (1994) (1)
The prevalence of viruses and bacteria in the respiratory tract of pre-school children from a Vanuatu village community and the relationship with certain environmental variables. (1988) (1)
The pros and cons of immunisation -- Paper two: the importance of immunisation. (1995) (1)
Characterization of a precipitating antigen detected in the serum of patients with viral hepatitis (1983) (1)
ISSUES ABOUT PERTUSSIS VACCINES. AUTHOR'S REPLY (1998) (0)
Some issues raised by the current influenza H5N1 outbreak. (2007) (0)
Managing vaccine development in a virtual organisation. (2002) (0)
Hepatitis B in the Western Pacific and South East Asia TABLE II Phrevalence ofHBeAg in adult carriers ofHBsAg Percentage (0)
General Preventative Measures (2018) (0)
Influenza pandemic vaccines: the imminent challenges from a technical and regulatory perspective (2004) (0)
CSL, from blood stock to blue chip (2020) (0)
Hepatitis A vaccine development: a personal perspective (2002) (0)
Current status of active immunization against hepatitis B infections. (1985) (0)
From discovery to commercialisation of vaccines (2010) (0)
RECENT ADVANCES IN VIRAL HEPATITIS (1977) (0)
Radio-immuno-precipitation test for the detection of antibodies to australia antigen (1973) (0)
Hepatitis A vaccine development: a personal perspective - Commentary (2002) (0)
Hepatitis A Virus, Infection and Immunity (1998) (0)
Foerfarande Foer framstaellning of thoroughly purified and tre gaonger klonade the hepatitis A virus. (1986) (0)
The significance of hepatitis B antibody detectable by cross-over immunoelectrophoresis. (1973) (0)
The role of the public sector and philanthropy in vaccine development (2011) (0)
Medical virology: Progress in medical virology, Vol. 29 (1984) (0)
WVC Australia 2008: The next generation of vaccines (2009) (0)
Modern Concepts of Hepatitis A (2000) (0)
The physiochemical properties of hepatitis a virus (2018) (0)
REVIEW Planning for the next pandemic of influenza (2001) (0)
Charles Ronald Lucas MB BS, FRACP (2009) (0)
Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Discussion (1996) (0)
Viral hepatitis: Some reflections on a personal journey (2009) (0)
Biology of hav in cell culture (2018) (0)
The importance of delta virus infection in australia and the western pacific region (1992) (0)
The authors comment (1980) (0)
AIDS vaccines (1991) (0)
Orphan vaccines--bridging the gap. (2002) (0)
Study of the immunogenicity and infectivity of hepatitis B‐containing stabilized plasma‐protein solution (1986) (0)
Identification Of Hepatitis A Virus (2018) (0)
In vitro effectiveness of a combination of zidovudine and ansamycin against human immunodeficiency virus. (1988) (0)
Comparative adjuvant action of gamma insulin and alum. (1991) (0)
Infectious diseases 1979--"Go West (or East) young man (or woman)!". (1979) (0)
Features of Hepatitis A in Experimentally Infected Nonhuman Primates (2018) (0)
Public health control of HBV: worldwide HBV vaccination programme. (1991) (0)
Some thoughts on the children's vaccine initiative. (1995) (0)
Theprevalence ofhepatitis B infection amongsturban andruralpopulations inWesternSamoa (1981) (0)
Thoroughly purified and tre-gaonger klonade hepatite a virus. (1986) (0)
Landes Highlights (2013) (0)
Molecular Biological and Monoclonal Antibody Techniques (1985) (0)
Non‐A, non B hepatitis in Iraq (1989) (0)
Rapid Viral Diagnosis (1986) (0)
Indirect Immunofluorescence AssayfortheDetection ofHepatitis A Virus-Specific SerumImmunoglobulins (1986) (0)

This paper list is powered by the following services:

Other Resources About Ian Gust

en.wikipedia.org

What Schools Are Affiliated With Ian Gust?

Ian Gust is affiliated with the following schools:

Ian Gust's Academic­Influence.com Rankings